Publicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria de Navarra (25)

2024

  1. Magnetic Resonance-Guided Focused Ultrasound (MRgFUS)-Thalamotomy for Essential Tremor: Lesion Location and Clinical Outcomes

    Movement Disorders, Vol. 39, Núm. 6, pp. 1015-1025

  2. Structural neuroimaging changes associated with subjective cognitive decline from a clinical sample

    NeuroImage: Clinical, Vol. 42

2023

  1. Clinical utility of intraoperative arterial spin labeling for resection control in brain tumor surgery at 3 T

    NMR in Biomedicine, Vol. 36, Núm. 9

  2. Predicting Conversion from Subjective Cognitive Decline to Mild Cognitive Impairment and Alzheimer's Disease Dementia Using Ensemble Machine Learning

    Journal of Alzheimer's disease : JAD, Vol. 93, Núm. 1, pp. 125-140

2022

  1. Grey matter changes on brain MRI in subjective cognitive decline: a systematic review

    Alzheimer's Research and Therapy, Vol. 14, Núm. 1

  2. Performance evaluation of a preclinical SPECT/CT system for multi-animal and multi-isotope quantitative experiments

    Scientific Reports, Vol. 12, Núm. 1

2021

  1. A proof-of-concept study of the in-vivo validation of a computational fluid dynamics model of personalized radioembolization

    Scientific Reports, Vol. 11, Núm. 1

  2. Blood pressure and risk of cognitive impairment: The role of vascular disease in neurodegeneration

    Brain Sciences, Vol. 11, Núm. 3

  3. Breath-Hold Induced Cerebrovascular Reactivity Measurements Using Optimized Pseudocontinuous Arterial Spin Labeling

    Frontiers in Physiology, Vol. 12

  4. Endolymphatic Hydrops in Fluctuating Hearing Loss and Recurrent Vertigo

    Frontiers in Surgery, Vol. 8

  5. Evaluation of the role of thyroid scintigraphy in the differential diagnosis of thyrotoxicosis

    Clinical Endocrinology, Vol. 94, Núm. 3, pp. 466-472

  6. Imaging of Stroke in Rodents Using a Clinical Scanner and Inductively Coupled Specially Designed Receiver Coils

    Annals of Biomedical Engineering, Vol. 49, Núm. 2, pp. 746-756

  7. Mixed pathologies in pancreatic β cells from subjects with neurodegenerative diseases and their interaction with prion protein

    Acta Neuropathologica Communications, Vol. 9, Núm. 1

  8. Ultra-low dose whole-body CT for attenuation correction in a dual tracer PET/CT protocol for multiple myeloma

    Physica Medica, Vol. 84, pp. 1-9

2020

  1. Elevated circulating metalloproteinase 7 predicts recurrent cardiovascular events in patients with carotid stenosis: A prospective cohort study

    BMC Cardiovascular Disorders, Vol. 20, Núm. 1

  2. Impact of the dosimetry approach on the resulting 90Y radioembolization planned absorbed doses based on 99mTc-MAA SPECT-CT: is there agreement between dosimetry methods?

    EJNMMI Physics, Vol. 7, Núm. 1

  3. Multicenter Validation of Metabolic Abnormalities Related to PSP According to the MDS-PSP Criteria

    Movement Disorders, Vol. 35, Núm. 11, pp. 2009-2018

2019

  1. Amylin as a potential link between type 2 diabetes and alzheimer disease

    Annals of Neurology, Vol. 86, Núm. 4, pp. 539-551

2018

  1. DNX-2401, an oncolytic virus, for the treatment of newly diagnosed diffuse intrinsic pontine gliomas: A case report

    Frontiers in Oncology, Vol. 8, Núm. MAR

  2. Significant dose reduction is feasible in FDG PET/CT protocols without compromising diagnostic quality

    Physica Medica, Vol. 46, pp. 134-139